Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan M Shumway

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Cancer|January 8, 2014
Future directions for monitoring treatment responses in breast cancerMatthew P Shupe, Lindsey J Graham, Erika J Schneble, et al.
Oncotarget|September 3, 2016
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrenceElizabeth A Mittendorf, Alexandros Ardavanis, Jennifer K Litton, et al.
Journal of Cancer|January 8, 2014
Current approaches and challenges in monitoring treatment responses in breast cancerLindsey J Graham, Matthew P Shupe, Erika J Schneble, et al.
Journal of Cancer|May 3, 2014
Current approaches and challenges in early detection of breast cancer recurrenceErika J Schneble, Lindsey J Graham, Matthew P Shupe, et al.
Journal of Cancer|May 3, 2014
Future directions for the early detection of recurrent breast cancerErika J Schneble, Lindsey J Graham, Matthew P Shupe, et al.
JCO Oncology Practice|April 10, 2026
Remote Therapeutic Monitoring and Infection-Related Health Care Resource Utilization in Patients With Hematologic MalignanciesBenjamin A Derman, James H Essell, Mustafa S Ascha, et al.
Expert Opinion on Biological Therapy|September 8, 2011
AE37: a novel T-cell-eliciting vaccine for breast cancerAlan K Sears, Sonia A Perez, Guy T Clifton, et al.
Breast Cancer Research and Treatment|April 24, 2020
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrenceTommy A Brown, Elizabeth A Mittendorf, Diane F Hale, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Cancer|January 8, 2014
Future directions for monitoring treatment responses in breast cancerMatthew P Shupe, Lindsey J Graham, Erika J Schneble, et al.
Oncotarget|September 3, 2016
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrenceElizabeth A Mittendorf, Alexandros Ardavanis, Jennifer K Litton, et al.
Journal of Cancer|January 8, 2014
Current approaches and challenges in monitoring treatment responses in breast cancerLindsey J Graham, Matthew P Shupe, Erika J Schneble, et al.
Journal of Cancer|May 3, 2014
Current approaches and challenges in early detection of breast cancer recurrenceErika J Schneble, Lindsey J Graham, Matthew P Shupe, et al.
Journal of Cancer|May 3, 2014
Future directions for the early detection of recurrent breast cancerErika J Schneble, Lindsey J Graham, Matthew P Shupe, et al.
JCO Oncology Practice|April 10, 2026
Remote Therapeutic Monitoring and Infection-Related Health Care Resource Utilization in Patients With Hematologic MalignanciesBenjamin A Derman, James H Essell, Mustafa S Ascha, et al.
Expert Opinion on Biological Therapy|September 8, 2011
AE37: a novel T-cell-eliciting vaccine for breast cancerAlan K Sears, Sonia A Perez, Guy T Clifton, et al.
Breast Cancer Research and Treatment|April 24, 2020
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrenceTommy A Brown, Elizabeth A Mittendorf, Diane F Hale, et al.
Pageof 2